Related by context. All words. (Click for frequent words.) 68 surrogate marker 68 stratifying patients 66 AST ALT 65 inflammatory biomarkers 65 serum markers 65 metabolic parameters 65 hematopoietic cancers 64 prognostic indicators 64 β blockers 64 HSCT 64 chemosensitivity 63 spirometric 63 prostate carcinoma 63 HER2 expression 63 microsatellite instability 63 surrogate endpoint 63 K ras mutations 63 residual confounding 63 cranial irradiation 63 cardiac troponin 63 pharmacodynamic endpoints 63 autonomic dysfunction 63 KRAS status 63 haematologic 63 posttransplant 63 genotypic resistance 63 fructosamine 63 conventional angiography 62 pharmacodynamic parameters 62 antibiotic regimens 62 covariate 62 CTEPH 62 gastric carcinoma 62 intraventricular 62 Subgroup analyzes 62 renal cysts 62 APOE genotype 62 diagnostic biomarker 62 endothelial activation 62 intact parathyroid hormone 62 aminotransferase 62 unmeasured confounders 62 gene polymorphisms 62 adjuvant therapies 62 immunohistochemical 62 antidiabetic medications 62 intima media thickness 62 serum albumin 62 antibody titer 62 paricalcitol 62 anti angiogenic agents 62 Tasigna prolongs 62 CYP #A# 62 prognostic significance 62 Cystatin C 62 receptor inhibitor 62 liver metastasis 62 scintigraphic 62 prostate cancer PCa 62 tumorigenicity 62 cTnT 62 myocardial ischaemia 62 prognostic marker 61 FDG PET scans 61 prognostic indicator 61 carotid plaque 61 alanine aminotransferase ALT 61 antiplatelet therapies 61 radiographic findings 61 plasma lipid 61 colorectal adenoma 61 rBChE 61 serum lipid levels 61 aspartate aminotransferase AST 61 LVNC 61 MTT assay 61 nonoperative treatment 61 fulvestrant 61 serum lactate 61 transgene expression 61 prognostic biomarker 61 biochemical abnormalities 61 tumor histology 61 lactate dehydrogenase 61 F FDG PET 61 serum IgE 61 myocardial viability 61 physiologic parameters 61 sonographic diagnosis 61 molecular biomarkers 61 plasminogen activators 61 transient elastography 61 Genetic variants 61 eculizumab therapy 61 prognostically 61 estimated GFR 61 MGUS 61 prognostic markers 61 TNF blocker therapy 61 airway responsiveness 61 cardiac troponin T 61 CSF biomarkers 61 CYP #D# 61 liver histology 61 oxysterols 61 electrophysiologic 61 apolipoproteins 61 thickness IMT 61 alkaline phosphatase ALP 61 carotid IMT 61 pulmonary arterial 61 SCr 61 carotid intima media 61 developmental neurotoxicity 61 logistic regression analysis 61 plasma pharmacokinetics 61 allogeneic HSCT 61 urine cytology 61 carotid plaques 61 S. maltophilia 61 hormone receptor status 61 prognostic variables 61 FDG PET imaging 61 hyperplastic polyps 61 IGRAs 61 pretransplant 61 thyroid carcinoma 61 arteriography 61 echocardiographic parameters 61 latent celiac disease 61 albumin excretion 60 exhaled nitric oxide 60 antioxidant supplementation 60 immunomodulation 60 preoperative diagnosis 60 PTPN# 60 ERK signaling 60 BEXXAR Therapeutic Regimen 60 glutamyl 60 neurocognitive function 60 secretory pathway 60 clinicopathological 60 PNH patients 60 hemodynamic parameters 60 bone scintigraphy 60 p#INK#a 60 motor neuron degeneration 60 serum lipid 60 preserved ejection fraction 60 pharmacokinetic parameters 60 riociguat 60 receptor subtypes 60 coexpression 60 prospectively defined 60 thyrotropin 60 abnormal glucose metabolism 60 antidiabetic drugs 60 immune modulating 60 glomerular filtration rate 60 perioperative morbidity 60 tissue oxygenation 60 TMPRSS2 ERG fusion 60 serologic tests 60 biochemical marker 60 erythropoietic 60 thyroid stimulating hormone 60 monoclonal gammopathy 60 QTc prolongation 60 florbetaben 60 TNFa 60 thyroglobulin 60 macroalbuminuria 60 selective modulator 60 caspofungin 60 histopathological 60 renoprotective 60 chorioamnionitis 60 troponins 60 adverse cytogenetics 60 bovine thrombin 60 pharmacokinetic interaction 60 mitochondrial toxicity 60 underlying pathophysiology 60 cerebral perfusion 60 CP CPPS 60 creatine supplementation 60 serum biomarkers 60 chromosomal rearrangement 60 immunochemical fecal occult 60 ABCB1 60 univariate analyzes 60 TPMT 60 mechanistic insights 60 p# activation 60 cystatin C 60 AChE inhibitors 60 mucinous 60 nongenetic 60 metaplasia 60 pharmacodynamic markers 60 normoxic 60 Adjuvant chemotherapy 60 lipid lowering therapies 60 endometrial hyperplasia 60 hamartomas 60 nephrotoxicity 60 adipokines 60 chest radiographs 60 macrolide antibiotic 60 therapeutic regimens 60 lactate dehydrogenase LDH 60 multivariate analyzes 60 androgen ablation 60 anticholinergic agents 60 etiologic 60 recurrent glioblastoma multiforme 60 nondiabetic patients 60 carotid bruit 60 EGFR expression 60 epithelial tumors 59 bronchoalveolar lavage 59 haematopoietic 59 FDG PET 59 remnant lipoproteins 59 hypercoagulable 59 hepatocellular carcinomas 59 GAMMAGARD 59 inotropic 59 atherogenesis 59 Observational studies 59 gene locus 59 Chronic pancreatitis 59 aminotransferase levels 59 extramedullary 59 lenalidomide dexamethasone 59 GRNCM1 59 attain statistical significance 59 adenomatous 59 radiosensitivity 59 histopathologic examination 59 thymidine 59 secretin 59 imatinib resistance 59 mTOR inhibitors 59 induced sputum 59 autologous transplantation 59 genetic polymorphisms 59 MGd 59 coronary calcification 59 TT genotype 59 glycosylated hemoglobin HbA1c 59 IPAH 59 multivariate logistic regression 59 conditional logistic regression 59 lipid lowering agents 59 pretest probability 59 vascular dysfunction 59 antiangiogenic therapy 59 leukocyte counts 59 MDRD 59 NGAL 59 vasogenic edema 59 hemodynamic variables 59 murine models 59 hepatic enzymes 59 hypothalamic pituitary 59 tumor necrosis 59 cTnI 59 SNP rs# [002] 59 etiologic agent 59 hyperacute 59 levosimendan 59 comorbid conditions 59 LV dysfunction 59 Multivariate analysis 59 transthoracic 59 urodynamic parameters 59 Leydig cell 59 concomitant medications 59 quasispecies 59 beta adrenergic receptor 59 thromboprophylaxis 59 hepatic fibrosis 59 echocardiographic 59 busulfan 59 multivariable analysis 59 CTAP# Capsules 59 intravesical therapy 59 hemoglobin hematocrit 59 PTEN gene 59 neuritic 59 biochemical markers 59 selenium supplementation 59 Rh factor 59 HIV HCV coinfected 59 overt hypothyroidism 59 artery stenosis 59 prostate carcinogenesis 59 calcineurin inhibitors 59 serum parathyroid hormone 59 aromatase inhibitor therapy 59 meta analytic 59 glycolytic 59 primary aldosteronism 59 myocyte 59 arterial calcification 59 glomerular filtration 59 carcinoids 59 skeletal metastases 59 hypoperfusion 59 parathyroidectomy 59 Cardiorespiratory fitness 59 cardiac biomarkers 59 pharmacokinetic interactions 59 hypericin 59 Bonferroni correction 59 urothelial cancer 59 neuroregenerative 59 diabetic kidney 59 VTE prophylaxis 59 histologic subtypes 59 ImmuKnow assay 59 antiplatelet drugs 59 clinical endpoints 59 cytochrome oxidase 59 primary hyperparathyroidism 59 NNRTI resistance 59 colorectal liver metastases 59 vascular reactivity 59 nephron sparing surgery 59 vasopressor 59 RBP4 59 hydroxy vitamin D 59 small molecule activators 59 biologic plausibility 59 antiphospholipid syndrome 59 angiographically 59 bivariate analysis 59 cellular prion protein 59 Telomere length 59 pharmacodynamic PD 59 subgroup analyzes 59 hematological parameters 59 Primary endpoints 59 cofactors 59 isolated systolic hypertension 59 electron beam computed tomography 59 physico chemical properties 59 serum concentrations 59 silent myocardial ischemia 59 KRAS mutation status 59 cardioprotective effects 59 methodologic 59 lymph node metastasis 59 eosinophil count 59 airway hyperresponsiveness 59 macrovascular events 59 Genetic predisposition 59 noncardiac 59 pathophysiologic 59 parasitemia 59 immunosuppressive regimen 59 chemopreventive agent 59 bronchoalveolar lavage fluid 59 intraobserver 59 PlGF 58 KRAS oncogene 58 dietary carbohydrate 58 β amyloid 58 STAT3 signaling 58 left ventricular diastolic 58 postmenopausal estrogen 58 gene amplification 58 Fas ligand 58 VEGF expression 58 PON1 58 genomic biomarker 58 natriuretic peptides 58 somatostatin receptor 58 Subgroup analysis 58 Angiotensin converting enzyme 58 lipid abnormalities 58 glycated hemoglobin levels 58 pharmacologic treatments 58 apolipoprotein B 58 metabolite concentrations 58 exocrine pancreas 58 differentially expressed genes 58 predictive biomarker 58 cardiac perfusion 58 electroencephalographic 58 Her2/neu 58 histological subtype 58 glomerular 58 immunomodulatory therapy 58 myopathies 58 KRAS mutation 58 urothelial carcinoma 58 sociodemographic factors 58 myeloperoxidase 58 Lp PLA 2 58 RQ PCR 58 antiphospholipid antibodies 58 Clusterin 58 HER2 overexpression 58 incidentalomas 58 Liver biopsy 58 #m Tc 58 leukocytosis 58 multiple logistic regression 58 G6PD deficiency 58 endogenous opioid 58 vidofludimus 58 muscarinic receptors 58 anti JCV antibodies 58 pyrimidines 58 VADT 58 renal toxicity 58 immunohistochemical analysis 58 immunohistochemical staining 58 Meta analyzes 58 intestinal permeability 58 GBA mutations 58 androgen suppression 58 nonpharmacologic 58 cathepsin K 58 pituitary adenomas 58 biomarker 58 pharmacologic intervention 58 poor metabolizers 58 osteocalcin protein 58 elevated LDH 58 newer atypical antipsychotics 58 autophagic 58 NOD mouse 58 metabolic acidosis 58 Xanafide 58 peptide BNP 58 bronchoalveolar 58 sCJD 58 antiarrhythmic 58 intracoronary 58 prostate cancer CaP 58 pulmonary metastases 58 hemoglobins 58 clinically meaningful 58 oral antidiabetic agents 58 myelofibrosis polycythemia vera 58 μmol L 58 tryptase 58 nodal metastases 58 PEDF 58 neurologic progression 58 GSTP1 58 biomarkers 58 Xenopus embryos 58 serum aminotransferase levels 58 serum thyroglobulin 58 computed tomographic scans 58 leukocyte count 58 nonalcoholic steatohepatitis 58 Cardiopulmonary bypass 58 lymphocytic 58 prognostic factors 58 PI3K signaling 58 clinicopathologic 58 TCF#L# gene 58 Adverse effects 58 logistic regression models 58 albumin excretion rate 58 acetabular fractures 58 hepatic enzyme 58 liver transplant recipients 58 serum BDNF 58 mutated K ras 58 myocardial perfusion 58 chemoprevention trials 58 osteopenic 58 bFGF 58 Elevated serum 58 circulating endothelial cells 58 efficacy endpoint 58 Skeletal muscle 58 antiarrhythmic medications 58 SNP rs# [001] 58 DCCR 58 GnRH agonists 58 PET tracers 58 fetal malformations 58 treating neuropathic pain 58 NNT = 58 Cognitive impairment 58 #F FDG PET 58 Logistic regression 58 genomewide 58 virulence genes 58 SGPT 58 antithrombotic agents 58 radiolabeled 58 myometrium 58 Non inferiority 58 overt nephropathy 58 Kruskal Wallis test 58 neurodevelopmental outcome 58 neoplastic 58 posttreatment 58 tigecycline 58 graft patency 58 FDG uptake 58 thoracoscopic lobectomy 58 miRNA expression 58 #F FDG 58 SERMs 58 antiepileptics 58 Lymph node 58 MAGE A3 ASCI 58 serum triglycerides 58 radioimmunoassay 58 creatine kinase MB 58 CORE OM 58 biodistribution 58 pathophysiologic mechanism 58 kallikrein 58 ABL1 58 hydroxyvitamin D levels 58 potent inducer 58 multivariate Cox 58 Hedgehog inhibitor 58 teratogens 58 differential gene expression 58 lipid lowering therapy 58 mycophenolate mofetil 58 isotypes 58 NPM1 mutation 58 dopamine transporter 58 karyotypes 58 dietary folate 58 hemodynamically significant 58 logistic regression analyzes 58 cerebral vasospasm 58 plasma lipoprotein 58 Riluzole 58 alpha fetoprotein AFP 58 immunoglobulin G 58 serologic 58 AGHD 58 interstitial fibrosis 58 cerebrospinal fluid CSF 58 LHRH agonists 58 adjuvant trastuzumab 58 estrone 58 micrometastasis 58 humoral responses 58 eplerenone 58 pCR 58 MTHFD1L gene 58 anti androgen 58 thrombolytics 58 Lipoic acid 58 bronchoalveolar lavage BAL 58 methotrexate monotherapy 57 Postoperative complications 57 FGFs 57 ventilation perfusion 57 Histologic 57 Immunohistochemical staining 57 neurobehavioural 57 Endothelial function 57 aminotransferases 57 TOP2A gene 57 Fc receptor 57 unmeasured factors 57 heparanase 57 clevidipine 57 hemoglobin Hb 57 neutrophil gelatinase associated lipocalin 57 Methotrexate MTX 57 cardiac contractility 57 renal biopsy 57 GSTT1 57 nitrotyrosine 57 rFVIIa 57 IGFBP 3 57 adrenalectomy 57 carotid artery thickness 57 myeloproliferative diseases 57 basal cell nevus syndrome 57 metastatic lymph nodes 57 canakinumab 57 oral anticoagulation 57 STRIDE PD 57 Pseudomonas aeruginosa infections 57 K ras mutation 57 baroreceptor 57 histologic findings 57 HRQL 57 immunoblotting 57 gene loci 57 bladder carcinoma 57 Amino acid 57 cardiac dysfunction 57 pyridostigmine 57 aldosterone antagonist 57 pain palliation 57 thiazide 57 oncological outcomes 57 pituitary hormone 57 imatinib Gleevec 57 histopathologic 57 elevated homocysteine 57 flavopiridol 57 Poisson regression 57 diagnostic modality 57 Fasting glucose 57 Hurthle cell 57 CVD mortality 57 inotropic agents 57 central corneal thickness 57 D Dimer 57 E selectin 57 Endothelial dysfunction 57 IGF IR 57 genomic alterations 57 gene polymorphism 57 catheter angiography 57 HAART regimens 57 H#Y 57 TNFalpha 57 TRUS biopsy 57 interobserver agreement 57 Microalbuminuria 57 mitochondrial metabolism 57 hematological relapse 57 MTHFR 57 angiotensin receptor blockers ARBs 57 antigen PSA levels 57 IgA deficiency 57 biomarker assay 57 leiomyomas 57 demyelinating 57 thrombin receptor 57 modifier genes 57 Multiple logistic regression 57 Treg cell 57 NAbs 57 CYP#A# inhibitors 57 nucleotide substitutions 57 reperfusion therapy 57 ADAS Cog 57 rhGH 57 bile acid metabolism 57 erythropoietin stimulating agents 57 fFN 57 p# biomarker 57 LRP5 57 fluvastatin 57 testosterone supplementation 57 systolic dysfunction 57 lumbosacral spine 57 decompensated cirrhosis 57 renal fibrosis 57 cytologic 57 confounding variables 57 B7 H3 57 multivariable adjusted 57 interobserver 57 morphometric vertebral fractures 57 clomipramine 57 curative therapy 57 PPARγ 57 polycythemia vera PV 57 transabdominal 57 Haptoglobin 57 Combination therapy 57 hepatorenal syndrome 57 mediated inhibition 57 vivo potency 57 pulmonary artery catheterization 57 malignant nodules 57 hepatotoxic 57 normal karyotype 57 immunological responses 57 familial clustering 57 clinically insignificant 57 exploratory endpoints 57 urine NGAL 57 mecamylamine 57 edifoligide 57 NIHSS score 57 telomere lengths 57 D dimer 57 nerve conduction velocity 57 hypotensive 57 periprocedural MI 57 Secondary efficacy endpoints 57 familial aggregation 57 pelvic lymphadenectomy 57 Dasatinib 57 symptomatic VTE 57 confounder 57 natriuretic peptide 57 histone modifications 57 clinico pathological 57 graft dysfunction 57 Surgical resection 57 hypermethylated 57 lung epithelium 57 bronchial hyperresponsiveness 57 transaminase levels 57 Plasma concentrations 57 Angiotensin receptor blockers 57 anterior pituitary 57 glial tumors 57 somatostatin analogues 57 diffusion tensor 57 mitochondrial proteins 57 cytotoxicity assays 57 hibernating myocardium 57 soluble CD# 57 lipid parameters 57 pamidronate 57 cerebral oxygenation 57 sonographic appearance 57 immunoreactivity 57 postprocedure 57 ImmuKnow 57 fasting triglycerides 57 adrenocorticotropic hormone 57 antiangiogenic drugs 57 PSADT 57 pulmonary exacerbations 57 proliferative diabetic retinopathy 57 beta globin gene 57 precancer 57 potency selectivity 57 prothrombotic 57 murine model 57 percutaneous biopsy 57 urine albumin 57 pressor response 57 zoledronate 57 alteplase 57 LDL particle 57 E. faecalis 57 Lp PLA2 57 WNK1 57 #ß 57 replicase 57 microbiologic 57 epithelial barrier 57 acetylcysteine 57 MMP inhibitors 57 bronchopulmonary dysplasia BPD 57 nonvascular 57 VKORC1 57 autoregulation 57 C. pneumoniae 57 artifactual 57 jugular venous 57 vessel occlusion 57 spontaneous regression 57 bioprosthetic valve 57 chromosomal mutations 57 QTc intervals 57 Inhaled nitric oxide 57 graft occlusion 57 haematological 57 perfusion abnormalities 57 hydroxyvitamin D concentrations 57 troponin T 57 FISH fluorescence 57 mesenteric 57 growth hormone secretion 57 dimensional sonography 57 atherosclerosis regression 57 intravenous cyclophosphamide 57 serum calcium 57 anagrelide 57 genotypic 57 elevated serum creatinine 57 Multivariate logistic regression 57 Circulating tumor cells 57 ELISPOT assay 57 pro angiogenic 57 postprandial glycemia 57 anthropometric measures 57 hemodynamics 57 nonischemic 57 serum homocysteine 57 inotropes 57 metabolic disturbances 57 mechanical dyssynchrony 57 EGFR mutation status 57 HbA 1c levels 57 serum PSA 57 oligomerization 57 HbF 57 DFMO 57 direct thrombin inhibitors 57 hormone receptor negative 57 left ventricular systolic 57 CDK inhibitor 57 serotonin synthesis 57 CYP#D# 57 Glucocorticoids 57 thromboembolic 57 postoperative hemorrhage 57 histologies 57 APOE e4 57 EBUS FNA 57 Corus CAD 57 histologic subtype 57 calcium homeostasis 57 dose Iluvien 57 radioligand 57 subclinical disease 57 plasma renin activity 57 ejection fractions 57 sulphonylureas 57 neuropathological 57 cediranib 57 hydroxylase 57 Thyroid hormone 57 acting insulin analogues 57 Dr. Borlongan 57 serum phosphorous 57 gross hematuria 57 esophageal carcinoma 57 PCR assay 57 BRAF V#E mutation 57 pulmonary dysfunction 57 atherogenic dyslipidemia 57 INCB# [003] 57 INVEGA ® 57 serum phosphate 57 teriflunomide 57 gadolinium enhanced 57 shorter telomere length 57 ertapenem 57 spiral computed tomography 57 colonoscopic 57 pairwise comparisons 57 multivariable Cox 57 pretargeting 57 hematopoietic cells 57 C1q 57 dobutamine 57 QRS interval 57 specific antigen PSA 57 IFN beta 57 Oral corticosteroids 57 autopsied brains 57 extracapsular extension 57 liposomal amphotericin B 57 NMES 57 adiponectin levels 57 transvaginal sonography 57 causative mutation 57 thiopurine 57 conventional coronary angiography 57 dyssynchrony 57 ascertainment bias 57 psychiatric comorbidity 57 postmenopausal hormones 57 chitinase 57 penetrance 57 microdose 57 CC genotype 57 cardioprotective effect 57 univariate 57 teratogenicity 57 femoral neck fracture 57 neurosensory 57 activated partial thromboplastin 57 Randomized trials 57 EGFR tyrosine kinase inhibitors 57 myocardial reperfusion 57 perfusion MRI 57 osteoblastic 57 pentoxifylline 57 coronary stenosis 57 agonist induced 57 statin medications 57 diagnose Alzheimer disease 57 fasting glucose levels 57 BCR ABL mutations 57 cardiovascular morbidity 57 steroidogenic 57 adrenal insufficiency 57 acute aortic dissection 57 perfusion imaging 57 pharmacokinetic PK profile 57 psychosocial variables 57 sleeve lobectomy 57 S#A# [002] 56 nonhematologic adverse reactions 56 endocrinologic 56 optimal dosing 56 viable myocardium 56 DEXA scans 56 sonographically guided 56 chemokine receptor 56 Cathepsin B 56 VEGFR1 56 Cardiotoxicity 56 potent inhibitors 56 phenotypic expression 56 antidiabetic therapy 56 alkaline phosphatase 56 antithrombotic 56 serum urate 56 hepatocellular 56 pancreatic adenocarcinoma 56 IL 1ß 56 blood clotting protein 56 ovarian hormones 56 pleural fluid 56 Chlamydia pneumoniae 56 MDRD equation 56 pulmonary resection 56 CEACAM1 56 left ventricular dysfunction 56 randomized controlled trials RCTs 56 pleiotropic effects 56 thromboembolic disease 56 methotrexate therapy 56 activated microglia 56 cathepsins 56 DNA methylation patterns 56 thetreatment 56 ADVEXIN therapy 56 bezafibrate 56 histologic 56 HIV tropism 56 hemodynamically unstable 56 hepatotoxicity 56 prospective multicenter study 56 virological response 56 Androgen 56 cardiac repolarization 56 glycosylated 56 chest radiography 56 inhibitor RG# 56 serum biomarker 56 atherogenic 56 neuropathologic 56 antiarrhythmic drugs 56 thermodynamic stability 56 Lipoprotein 56 IDDM 56 juvenile idiopathic arthritis JIA 56 neoplasias 56 ceruloplasmin 56 serum phosphate levels 56 hMG 56 hypercalciuria 56 coronary stenoses 56 postoperative AF 56 empiric treatment 56 basal bolus regimen 56 isoproterenol 56 intravenous bisphosphonates 56 subclinical atherosclerosis 56 S nitrosylation 56 aminotransferase ALT 56 PKC inhibitors 56 5q deletion 56 serum GGT 56 Insulin detemir 56 papillary renal cell carcinoma 56 liver biopsies 56 PSA nadir 56 Granulocyte Colony Stimulating Factor 56 malabsorptive 56 oxidative stress markers 56 thalidomide Thalomid 56 pulmonary angiography 56 vitro assay 56 COL#A# 56 aetiological 56 pulmonary toxicity 56 prognostic factor 56 clade B 56 LDL HDL 56 Kaplan Meier analysis 56 plasma lipids 56 telomerase inhibition 56 postoperative morbidity 56 esophageal reflux 56 cAMP signaling 56 grade cervical intraepithelial 56 microvascular disease 56 multivariate regression analysis 56 monogenic 56 aspartate aminotransferase 56 intestinal mucosal 56 scintigraphy 56 nicardipine 56 androgen deprivation